key: cord-0921235-3orbhvqc
authors: Singh, Balraj; Kaur, Parminder; Reid, Ro-Jay; Shamoon, Fayez; Bikkina, Mahesh
title: COVID-19 and Influenza Co-Infection: Report of Three Cases
date: 2020-08-18
journal: Cureus
DOI: 10.7759/cureus.9852
sha: 736d752175f1e63bbf4a7640a2a458c2efca8e29
doc_id: 921235
cord_uid: 3orbhvqc

Influenza and coronavirus disease 2019 (COVID-19) are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 pandemic is caused by a novel virus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Influenza is an infectious respiratory disease, caused by influenza A and influenza B viruses. We describe the three cases of influenza and COVID-19 co-infection.

Coronavirus disease 2019 (COVID-19) originated in the Huanan South China Seafood Market in Wuhan. It has posed a global health threat. COVID-19 can present with a spectrum of clinical manifestations including fever, myalgia, cough, dyspnea, and less frequently headache, diarrhea, nausea, and vomiting. Although respiratory symptoms predominate, multiple organ dysfunction may also occur with COVID-19. Coagulopathy has been found as a prominent feature of COVID-19 and severe coagulation dysfunction may be associated with poor prognosis [1] [2] [3] . Neurological and cardiovascular complications are also common in COVID-19 patients. No effective treatment has yet been established.

The mean age was 59.6 years (range 47-71 years) and 2/3 were female. Two were Hispanic and one was Pilipino. Comorbidities included hypertension and diabetes mellitus. COVID-19 was diagnosed by nasopharyngeal swab reverse-transcription polymerase chain reaction (RT-PCR) and influenza by rapid antigen assay. Two patients had influenza type B and one had influenza type A. The presenting sign and symptoms were cough, fever, shortness of breath and myalgia. Chest X-ray (CXR) and computed tomography (CT) of the case 1 and case 2 are shown in Figure  1A -1D. 1 2 3 4 5

CXR: Chest X-ray

One patient (case 2) had positive blood culture for Enterococcus faecium. Two patients required intubation during their hospital course. Inflammatory markers (ESR, CRP, IL-6) were elevated in the patients. All three patients were treated with hydroxychloroquine, azithromycin, ceftriaxone for COVID-19 and Oseltamivir for influenza. All were discharged in stable condition. Reference ranges are as follows: white blood cells 4.5-11 K/mm 3 , hemoglobin 12-16 g/dl, platelets 140-440 K/mm 3 

In a metanalysis study, 3% of patients hospitalized with COVID-19 were also co-infected with another respiratory virus; respiratory syncytial virus (RSV) and influenza A being the most common viral pathogens identified [4] . Table 2 summarizes salient differences between the two viruses [4] [5] [6] [7] .

Virus characteristics 

In conclusion, we report three cases of co-infection of influenza and COVID-19. Health care providers should be aware of this unique situation as both can present with similar symptoms but vary in treatment. Clinicians should have a high index of suspicion in the appropriate clinical scenario. Further studies are needed to determine whether patients who have a concurrent viral infection have a worse prognosis than those in whom SARS-CoV-2 is the only detected pathogen.

Human subjects: Consent was obtained by all participants in this study.

In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to

Acute upper limb ischemia in a patient with COVID-19 (PREPRINT)

COVID-19 presenting as acute limb ischaemia

Covid-19 presenting as acute limb ischemia

Co-infections in people with COVID-19: a systematic review and meta-analysis

Neurological manifestations and complications of COVID-19: a literature review

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-ofthe-art review